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ABSTRACT 
The present study aimed to select strains of Bacillus thuringiensis with insecticidal activity against Aedes aegypti. It 
was tested sixteen strains of bacteria, isolated from Paraná state, Brazil, that were used in laboratory assays with 
mosquito larvae. Tests were carried out in two stages, first one to select the most efficient strains (screening) and 
second to estimate LC50. The protein profile of the highest toxicity of strain was obtained by SDS-PAGE (sodium 
dodecyl sulfate polyacrylamide gel electrophoresis). The best performance of larval mortality was produced by BR-
01 strain, which 96.7% mortality rate, significantly higher than others. In the second part, there was obtained a 
LC50 of 9.07 µL.L-1 fermented extract. The protein profile revealed many peptides between 15 and 140kDa, similar 
to that reported in Bacillus thuringiensis ser. israelensis strains which high toxicity to mosquito species.
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Seleção de cepas de Bacillus thuringiensis Berliner para o 
controle de Aedes aegypti Linnaeus 
RESUMO 
O presente trabalho buscou selecionar cepas de Bacillus thuringiensis com atividade inseticida contra Aedes aegypti. 
Foram testadas 16 estirpes da bactéria provenientes do estado do Paraná, Brasil, que foram utilizadas em ensaios 
laboratoriais com larvas do culicídeos. Os testes foram realizados em duas etapas, a primeira com a seleção de cepas 
e a segunda para estimar a CL50 das cepas com melhores resultados. O perfil protéico do isolado de maior toxicidade 
foi obtido por SDS-PAGE (dodecil sulfato de sódio – eletroforese em gel de poliacrilamida). O melhor resultado de 
mortalidade foi produzido com a cepa BR-01, que produziu 96,7% de mortalidade de A. aegypti, valor 
significativamente superior aos demais. Na segunda fase, obteve-se CL50 de 9,07 µL.L-1 de extrato fermentado. O 
perfil protéico revelou peptídeos entre 15 e 140kDa, resultado semelhante ao relatado nas cepas de Bacillus 
thuringiensis var. israelensis de maior toxicidade às espécies de culicídeos. 
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INTRODUCTION 
The Aedes aegypti Linnaeus is an insect extremely 
anthropophilic and is one of the main species of 
medical interest, related to the occurrence of 
several pathogens worldwide.  Endemic in tropical 
and subtropical areas in the four continents, the 
mosquito is widely adapted to urban environments, 
invading cities and human settlements. The insect 
is the major responsible to transmit dengue, urban 
yellow fever and other arboviroses. Its occurrence 
is usually related to the periods of summer rains 
until early drought during the winter, period that 
the diseases occurrence is increased (Barreto and 
Teixeira, 2008). In many countries, the presence of 
Aedes aegypti is constantly monitored as a control 
measure, mainly where dengue has high 
endemicity.  
From the understanding of the role of vector-borne 
insects Culicidae, strategies for combating 
diseases began to focus on vector control. The 
development of synthetic insecticides in the 
decade of 30, organophosphates and 
organochlorines, gave new impetus to combat 
mosquito populations. Thus, successful campaigns 
to dengue and yellow fever combat in the decade 
of 50 eliminated the presence of A. aegypti in 
many parts of the globe (Consoli and Lourenço-
de-Oliveira, 1994). However, after few decades 
the indiscriminate use of these substances has 
proved extremely harmful to humans and the 
environment.  
The insect resistance to chemical pesticides had 
been noticed, indicating that the combat strategies 
need to change. In this context, the research for 
alternative and less harmful pest control 
substances had started. The endotoxin produced by 
bacteria had shown a great potential, with 
efficiency and environmental safety. Produced 
with specificity to the target organism, the bio-
insecticides are not accumulate in the food chain, 
and harmless to humans and other animals 
(Rabinovitch et al., 1998). 
Bacillus thuringiensis (Bt) is a gram-positive 
spore-forming bacteria with aerobic growth, 
known as the main microorganisms used in the 
formulation of biological insecticides (Federici et 
al., 2010). The action mechanism is associated 
with bacterial endotoxin, that is activated in the 
larvae gut, and then disintegrates forming Cry 
proteins. Molecular interactions between these 
peptides and epithelial receptors trigger a 
cytopathic response, leading to larval death (Bravo 
et al., 2007). Frequently found in soil samples, the 
strains of B. thuringiensis are isolated by simple 
techniques with selective media and 
morphological analysis. Meanwhile, the toxicity 
can vary significantly according to polymorphism, 
increasing or decreasing the efficiency and 
specificity to the target organism. Thus, biological 
assays are essential in determining the strain of B. 
thuringiensis suitable for the formulation of 
biological insecticides 
This study aimed to evaluate the toxicity of B. 
thuringiensis strains forward to the 3rd instar 
larvae of Aedes aegypti using laboratory bioassays. 
The LC50 was estimated to the best strain; and its 
protein profiles determinate by SDS-PAGE 
(sodium dodecyl sulfate polyacrylamide gel 
electrophoresis). 
 
MATERIAL AND METHODS 
Bioinsecticide production 
Sixteen strains of Bacillus thuringiensis isolated 
from Paraná State, Brazil, and stored in 
Biotechnological and Bioprocess Laboratory 
(LPB-1) of the Federal University of Paraná 
(UFPR) were used to produce the bioinsecticide. 
The reactivation of the bacteria was carried out 
with the inoculation of 2.0 to 5.0 x 105CFU.mL-1 
into 50 mL Luria Bertani medium (Sambrook et 
al., 1989) in Erlenmeyer flasks, previously 
sterilized. The fermentation was carried in rotatory 
shaker at 120rpm at 30º C for 72h, and stored in 
refrigerator at 4º C until use. 
 
Mosquitoes 
The strain Rockfeller of Aedes aegypti maintained 
in the Molecular Parasitology Laboratory at the 
Federal University of Paraná, Brazil was used to 
bioassays. In order to obtain the larvae of 
mosquitoes, the adults were kept in cages (25cm x 
25cm) covered with mesh and maintained in a 
chamber at 28ºC (Melo et al., 2011). The adults 
were fed with an apple slice approximately 2cm2 
thick and 4cm long, replaced weekly. The blood 
meal was placed weekly, using newborn mice. The 
oviposition was done on filter papers inserted 
inside recipients with water (6cm x 6cm). The 
larvae were maintained in plastic trays (10cm x 
25cm) with approximately 400mL of 
dechlorinated water, changed every three days. 
They were fed with fish food (Alcon Pet®, 
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Bioassays 
The bioassays were performed in the same 
laboratory, based on the model recommended by 
WHO for experiments with the bacteria (WHO, 
2005). The biological tests were carried out in two 
steps: first for screening (to select the best strains) 
and second for estimating toxicity values (LC50). 
In the first part, we used 100L bacterial culture 
added to a flask with 20 third instar larvae in 100 
mL dechlorinated water. The tests were carried out 
in triplicate and three containers not received the 
product (negative control). After 24 hours, the 
counting of the number of living larvae was made 
and to estimate the mortality rate (%). If the 
negative control mortality was less than 20%, the 
tests were canceled and redone. The mortality 
values were corrected using Abbot's formula 
(1925). 
 
Abbott’s formula  
Larvae Mortality rate (%) = 100.(X – Y)/X 
x = rate of living larvae in negative control; y = rate of living larvae in treatment. 
 
In the second part, the strain that had more 
significant mortality (above 50%) was applied at 
five different dilutions (1, 5, 10, 15 and 25 µL.L-1 
fermented extract) under the same conditions of 
the previous experiment. The results were used to 
estimate of LC50 against A. aegypti. 
 
Statistical analysis 
All experiments were performed in triplicate. 
Mortality rate values from the first experiment 
(screening) were transformed to arcsine 100/x  
and submitted to analysis of variance (ANOVA) 
and the means were compared by the Scott-Knott 
test, both at P<0.05. The estimation of LC50 and 
the confidence intervals (95%) were calculated by 
the Trimmed Spearman-Karber method, using the 
software TSK, version 1.5 (USEPA, 1990). 
 
SDS-PAGE 
The protein profile of the strain with highest 
mortality rate was determinate. The biomass had 
suffered the reaction of sodium dodecyl sulfate 
and it was analyzed by gel electrophoresis in 15% 
polyacrylamide (Laemmli, 1970). After 
fractionation, the gel was stained for 10 minutes in 
coomassie blue solution and then placed in a 
solution of 7% acetic acid for removal of excess 
dye, until the protein fractions is sharp present. As 
reference molecular weight, we used the precision 
pre-stained molecular weight markers (BioRad). 
 
RESULTS AND DISCUSSION 
In the first experiment (screening), it was observed 
diversified results varying from 0 to 96.7% 




(Table 1). Eleven strains were innocuous, does not 
produce any mortality of larvae. Four were 
partially effective, with reduced toxicities, ranging 
from 16.7 to 48.3%. The best performance was 
produced by strain BR-01, which 96.7% mortality 
rate of A. aegypti larvae. This result was 
significantly higher than other strains, qualifying 
the strain for subsequent tests. 
 
Table 1. Mortality of larvae of Aedes aegypti 
produced by different strains of Bacillus 
thuringiensis isolated from the state of Paraná, 
Brazil, at 1000 µL.L-1. 
Strain Mortality (%) 
Negative control 0    d1 
BR-01 96.7 a 
BR-02 21.7 c 
BR-03 16.7 c 
BR-04 0 d 
BR-07 0 d 
BR-08 0 d 
BR-09 31.7 b 
BR-10 0 d 
BR-11 0 d 
BR-12 0  d 
BR-13 48.3 b 
BR-14 0 d 
BR-15 0 d 
BR-16 0 d 
BR-17 0 d 
BR-18 0 d 
1 Treatments followed by the same letter do not 
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Mosquito known as Bt susceptible specie, A. 
aegypti was not vulnerable to most isolates of the 
bacterial strains tested. In spite of contradictory, 
this result confirms the particular characteristics of 
B. thuringiensis. Although the bacterium is used to 
control a wide range of invertebrates, the 
endotoxin of B. thuringiensis shows specificity of 
the target organism. Therefore, strain which has 
affinity for a particular order, it does not have the 
same effect on another (Bravo et al. 2007). 
Knowing the wide variety of organisms potentially 
targets to Bt, the finding of native high toxicity 
Aedes aegypti can be considered a satisfactory 
result. 
The occurrence of non-toxic strains has been 
studied lately. According to Benintende et al. 
(1999), strains of Bt without biological action are 
more widely distributed than species that produce 
a toxic effect. Studying four non pathogenic 
strains of Bt, Roh et al. (2008) observed the  
 
presence of protein crystals similar to those found 
in pathogenic strains, however, with a different 
shape. Thus, the absence of toxic activity was not 
due to non-production of the Cry proteins, but not 
its affinity for the insect species tested. In this 
study, isolates with low or innocuous activity on 
A. aegypti larvae may show activity to other 
invertebrate species. But only in vivo or in vitro 
tests could confirm this hypothesis. 
In the second part, the mortality rate was variable 
according to the product concentration, ranging 
from 5 to 95% (Table 2). The LC50 for strain BR-
01 was 9.07 µL.L-1 fermented extract, ranging 
from 6.85 to 12 µL.L-1 fermented extract (Table 
2). The results were satisfactory for small scale 
fermentations, employing a not optimized culture 
medium. Knowing the potential of BR-01, 
fermentations in bioreactor and the use of local 
raw materials with low cost can surely enhance the 
performance of mortality of larvae.  
 
Table 2. Lethal concentration (LC50) of fermented extract of Bacillus thuringiensis strain BR-01 against 
Aedes aegypti after 24 hours. LC50 was estimated using trimmed Spearman-Karber. 
Concentration 
(µL.L-1) 













9.07 6.85-12.0 5.0 
15 75    
25 95    
 
The analysis of the BR-01 protein profile by SDS-
PAGE revealed a large amount of peptides, 
ranging from 15 to 140kDa as molecular weights 
(Figure 1). This result was consistent with the 
spectrum of the greatest toxicity strain, such 
Bacillus thuringiensis var. israelensis (Bti). 
Described as suitable for vector control, strain 
HD-73 produces Cry and Cyt proteins with high 
larvicidal action with 130, 70 and 27 kDa (Bravo 
et al. 2011, Guechicoff et al. 2001). Likewise, the 
isolated BR-01 showed a profile that contained 
peptides with molecular weights similar to strains 
of Bti. 
However, the presence of proteins similar to those 
found in strains of greater toxicity is no guarantee 
of biological activity. Benintende et al. (1999) 





verified by SDS-PAGE the existence of 130, 60 
and 40kDa proteins. But in biological assays with 
Lepidoptera, Coleoptera and Diptera, these strains 
did not show larvicidal activity, being harmless to 
organisms. Thus, the arrangement of protein 
profile analyzes and biological assays results can 
give a valuable data for understanding of 
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Figure 1: Profile of proteins from Bacillus 




The BR-01 strain showed the highest toxicity 
against A. aegypti larvae, producing LC50 of 9.07 
µL.L-1 fermented extract in a confidence interval 
from 6.85 to 12 µL.L-1 fermented extract. 
The protein profile has peptides between 15 and 
140kDa, similar to that reported with the greatest 
toxicity Bti strains. 
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